fashion -WSS

fashion

author：fashion 2025-09-30 04:59:47 - browse：15928

the White House and the lawn in front of it shows behind a railing – coverage from STAT — Mark Wilson/Getty Images

President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how AI is used — and how much it costs — in areas from drug research to hospital care.

The order, released in full detail late Monday, calls for two elements of AI oversight that are currently nonexistent in health care: a policy, or independent body, that would test and assure the quality of AI tools, and a “central tracking repository” to report clinical errors associated with the use of the technology.

AI standards bodies in health care have previously pitched both ideas, but throwing the weight of the federal government behind them is more likely to bring them to fruition. Biden’s orders all require action before next fall’s election, a timeline designed to build momentum behind regulations that may be harder for a successor with different ideas to reverse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： WHO recommends second malaria vaccine

hotspot

focus

WSS

Microsoft launches AI tool for clinical documentation through Epic

What we owe ALS patients — and why one company fell short

New oral drug delivery patch is modeled after octopus tentacles

Will an HIV vaccine ever be a reality?

Pumping milk in bathrooms at health conferences is common

The United States is paying nearly triple for new Covid vaccines

Wikipedia

fashion

leisure time

At least 13 dead in Texas as scorching temps continue

Medicare innovation center doesn’t save money, experts say

Novavax promises a turnaround & Lilly roils the obesity market

Printout prescription drug information shouldn’t go digital

The cancer drug shortage isn’t new — and neither are the solutions

Setback for rare diseases as Taysha Gene Therapies pulls back

What does generative AI mean for health care? We asked experts

There's an unseen cost to disruptive road

DIEP, the 'gold standard' of breast reconstruction, is under threat

WHO recommends second malaria vaccine

knowledge

Maisha Meds is a PBM, but don't call it that

HPV vaccine, cervical cancer study delivers historic results

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

New oral drug delivery patch is modeled after octopus tentacles

The United States is paying nearly triple for new Covid vaccines

hotspot

hotspot

focus

Wikipedia